S-(5'-Adenosyl)-L-homocysteine-13C5

• Catalog No.: A291502
• M. F.: C14H20N6O5S
• M. W.: 389.37407419

SYNONYMS

• IUPAC name: (2S)-2-amino-4-({[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxy(2,3,4,5-^1^3C₄)oxolan-2-yl](^1^3C)methyl}sulfanyl)butanoic acid
• IUPAC Traditional name: (2S)-2-amino-4-({[(2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy(2,3,4,5-^1^3C₄)oxolan-2-yl](^1^3C)methyl}sulfanyl)butanoic acid
• Synonyms: S-(5'-Deoxyadenosin-5'-yl)-L-homocysteine-13C5; L-5'-S-(3-Amino-3-carboxypropyl)-5'-thioadenosine-13C5; Adenosylhomocysteine-13C5; L-S-Adenosylhomocysteine-13C5; S-Adenosyl-L-homocysteine-13C5; Adenosyl-L-homocysteine-13C5; S-Adenosylhomocysteine-13C5

DETAILS

Description (English)

A novel labelled biomarker for predicting susceptibility of a subject to a mental or neurodegenerative disorder.

REFERENCES

• Chamberlin, M., et al.: J. Clin. Invest., 98, 1021 (1996)
• Zoccolella, S., et al.: Neurology, 70, 222 (1996)